PaladinoJA. Linezolid: an oxazolidinone antimicrobial agent. Am J Health Syst Pharm2002; 59: 2413–25.
2.
PillaiSKSakoulasGWennerstenCEliopoulosGMMoelleringRCFerraroMJ, Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype. J Infect Dis2002; 186: 1603–7.
3.
TsiodrasSGoldHSSakoulasGEliopoulosGMWennerstenCVenkataramanL, Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet2002; 358: 207–8.
4.
PrystowskyJSiddiquiFChosayJShinabargerDLMillichapJPetersonLR, Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob Agents Chemother2001; 45: 2154–6.
5.
WilsonPAndrewsJACharlesworthRWalesbyRSingerMFarrellDJ, Linezolid resistance in clinical isolates of Staphylococcus aureus. J Antimicrob Chemother2003; 51: 186–8.
6.
HerreroIAIssaNCPatelR. Nosocomial spread of linezolid-resistant vancomycin-resistant Enterococcus faecium. N Engl J Med2002; 346: 867–9.
7.
AucklandCTeareLCookeFKaufmannMEWarnerMJonesG, Linezolid-resistant enterococci: report of the first isolates in the United Kingdom. J Antimicrob Chemother2002; 50: 743–6.
8.
EnneVHoweRAWalshTRMutnickAHJonesRN. Initial descriptions of linezolid resistance in S. epidermidis and Streptococcus oralis: report from the SENTRY Antimicrobial Surveillance Program (abstract LB-10). Presented at: The 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, September 27–30, 2002.
9.
BozdoganGPatelMVGupteS VDe SouzaNJKhorakiwalaHFGreenivasK, Characterization of linezolid resistant mutants of Staphylococcus aureus and Streptococcus pneumoniae isolated from mouse in terms of 23S rRNA mutations (abstract 1609). Presented at: The 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, September 27–30, 2002.
10.
MutnickAHEnneVJonesRN. Linezolid resistance since 2001: SENTRY Antimicrobial Surveillance Program. Ann Pharmacother2003; 37: 769–74. DOI 10.1345/aph.1C437.
11.
JonesRNDella-LattaPLeeLVBiedenbachDJ. Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY antimicrobial surveillance network. Diagn Microbiol Infect Dis2002; 42: 137–9.
12.
KahlmeterGBrownDFJ. Resistance surveillance studies — comparability of results and quality assurance of methods. J Antimicrob Chemother2002; 50: 775–7.
13.
MutnickAHBiedenbachDJTurnidgeJDJonesRN. Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998–2000. Diagn Microbiol Infect Dis2002; 43: 65–73.
14.
HoweRANoelARBowkerKEBennettPMWalshTRMacGowanAP. Linezolid resistance in Streptococcus pneumoniae (abstract 1611). Presented at: The 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, September 27–30, 2002.
15.
GupteSVSreenivasKNairSUpadhyayDJPatelMVKhorakiwalaHF, Selection of linezolid resistant mutants of MSSA, MRSA and pneumococci in murine infections (abstract 1610). Presented at: The 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, September 27–30, 2002.
16.
RaadIIHannaHAArbuckleRAChaibanGDvorakTHachemRY. Susceptibility patterns of vancomycin-resistant enterococci to quinupristin/dalfopristin and linezolid before and after clinical use (abstract 1134). Presented at: The 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, September 27–30, 2002.
17.
SchroederLKSchreckenbergerPCKelkarSQuinnJP. Nosocomial super-infections due to ampicillin-sensitive, linezolid-resistant Enterococcus faecalis (abstract 1591). Presented at: The 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, September 27–30, 2002.
18.
JonesRNLowDEPfallerMA. Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds. Diagn Microbiol Infect Dis1999; 33: 101–12.
19.
BallowCHJonesRNBiedenbachDJ. A multicenter evaluation of linezolid antimicrobial activity in North America. Diagn Microbiol Infect Dis2002; 43: 75–83.